- Home
- MRUS vs NVG Comparison
MRUS vs NVG Comparison
Compare MRUS & NVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- NVG
- Stock Information
- Founded
- MRUS 2003
- NVG 1999
- Country
- MRUS Netherlands
- NVG United States
- Employees
- MRUS N/A
- NVG N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- NVG Investment Managers
- Sector
- MRUS Health Care
- NVG Finance
- Exchange
- MRUS Nasdaq
- NVG Nasdaq
- Market Cap
- MRUS 2.9B
- NVG 2.6B
- IPO Year
- MRUS 2016
- NVG N/A
- Fundamental
- Price
- MRUS $39.45
- NVG $12.38
- Analyst Decision
- MRUS Strong Buy
- NVG
- Analyst Count
- MRUS 12
- NVG 0
- Target Price
- MRUS $87.92
- NVG N/A
- AVG Volume (30 Days)
- MRUS 706.1K
- NVG 568.8K
- Earning Date
- MRUS 02-26-2025
- NVG 01-01-0001
- Dividend Yield
- MRUS N/A
- NVG 4.65%
- EPS Growth
- MRUS N/A
- NVG N/A
- EPS
- MRUS N/A
- NVG N/A
- Revenue
- MRUS $35,932,000.00
- NVG N/A
- Revenue This Year
- MRUS N/A
- NVG N/A
- Revenue Next Year
- MRUS $57.37
- NVG N/A
- P/E Ratio
- MRUS N/A
- NVG N/A
- Revenue Growth
- MRUS N/A
- NVG N/A
- 52 Week Low
- MRUS $31.62
- NVG $9.68
- 52 Week High
- MRUS $61.61
- NVG $12.21
- Technical
- Relative Strength Index (RSI)
- MRUS 38.07
- NVG 46.86
- Support Level
- MRUS $38.52
- NVG $12.16
- Resistance Level
- MRUS $47.75
- NVG $12.44
- Average True Range (ATR)
- MRUS 2.05
- NVG 0.13
- MACD
- MRUS -0.17
- NVG 0.03
- Stochastic Oscillator
- MRUS 16.83
- NVG 71.74
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.